Frontiers | Chronic Lymphocytic Leukemia B-Cell Normal Cellular Counterpart: Clues From a Functional Perspective | Immunology
PDF] Prognostic value of lymphocyte surface markers in acute myeloid leukemia. | Semantic Scholar
Cellular markers and new drugs in chronic lymphocytic leukemia (CLL). A... | Download Scientific Diagram
Chronic lymphocytic leukaemia - The Lancet
International Clinical Cytometry Society
Reprogramming Nurse-like Cells with Interferon γ to Interrupt Chronic Lymphocytic Leukemia Cell Survival* - Journal of Biological Chemistry
Target values for markers used in CLL MRD analysis. | Download Table
Modulated expression of adhesion, migration and activation molecules may predict the degree of response in chronic lymphocytic leukemia patients treated with ibrutinib plus rituximab | Haematologica
Surface-antigen expression profiling of B cell chronic lymphocytic leukemia: from the signature of specific disease subsets to the identification of markers with prognostic relevance | Journal of Translational Medicine | Full Text
Multidisciplinary diagnostics of chronic lymphocytic leukemia: European Research Initiative on CLL - ERIC recommendations | Hematology, Transfusion and Cell Therapy
Frontiers | Importance of Crosstalk Between Chronic Lymphocytic Leukemia Cells and the Stromal Microenvironment: Direct Contact, Soluble Factors, and Extracellular Vesicles | Oncology
IJMS | Free Full-Text | Immune Response Dysfunction in Chronic Lymphocytic Leukemia: Dissecting Molecular Mechanisms and Microenvironmental Conditions | HTML
Chronic lymphocytic leukemia–like monoclonal B-cell lymphocytosis exhibits an increased inflammatory signature that is reduced in early-stage chronic lymphocytic leukemia - Experimental Hematology
CD markers variations in chronic lymphocytic leukemia: New insights into prognosis - Vosoughi - 2019 - Journal of Cellular Physiology - Wiley Online Library
Chronic Lymphocytic Leukemia (CLL) Workup: Approach Considerations, Chromosomal Testing, Bone Marrow Aspiration and Biopsy
T-cells in chronic lymphocytic leukemia: Guardians or drivers of disease? | Leukemia
B-Cell Clones as Early Markers for Chronic Lymphocytic Leukemia | NEJM